Wedbush Reiterates Outperform on Imax, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Alicia Reese reiterated an Outperform rating on Imax (NYSE:IMAX), with a maintained price target of $22.
April 10, 2024 | 4:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Alicia Reese reiterated an Outperform rating on Imax, with a maintained price target of $22.
The reiteration of an Outperform rating by a reputable analyst like Alicia Reese, along with a maintained price target of $22, signals strong confidence in Imax's future performance. This endorsement is likely to positively influence investor sentiment and could lead to a short-term uptick in IMAX's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100